U.S. markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
119.35-0.40 (-0.33%)
Al cierre: 04:00PM EDT
118.78 -0.57 (-0.48%)
Fuera de horario: 07:51PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 373 3333
https://www.zimmerbiomet.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo18,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Ivan TornosCOO, President, CEO & Director2.72MN/D1975
Mr. Suketu P. UpadhyayCFO and Executive VP of Finance, Operations & Supply Chain2.01MN/D1969
Mr. Chad F. PhippsSenior VP, General Counsel & Secretary1.32M1.23M1972
Mr. Sang YiPresident of Asia Pacific1.38MN/D1962
Mr. Wilfred van ZuilenGroup President of Europe, Middle East & Africa1.47MN/D1970
Mr. Paul A. StellatoVP, Controller & Chief Accounting OfficerN/DN/D1975
Dr. Nitin Goyal M.D.Chief Science, Technology & Innovation OfficerN/DN/DN/D
Mr. Zeeshan TariqSenior VP & Chief Information OfficerN/DN/DN/D
Ms. Keri P. MattoxSVP and Chief Communications & Administration OfficerN/DN/DN/D
Mr. Zachary Ross Weiner CPADirector of Investor RelationsN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Gestión corporativa

La calificación ISS Governance QuickScore de Zimmer Biomet Holdings, Inc. a partir del 1 de abril de 2024 es 6. Las puntuaciones principales son Auditoría: 2; Junta: 3; Derechos del accionista: 4; Compensación: 10.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.